Repurposing Tigecycline for the Treatment of Alcohol Use Disorder.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Potential of Glial Cell Modulators in the Management of Substance Use Disorders.CNS drugs · 2020
   Review
2. Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice.Brain, behavior, & immunity - health · 2020
   Article
3. Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies.Alcoholism, clinical and experimental research · 2020
   Review
4. Novel Adenosine Analog,The Journal of pharmacology and experimental therapeutics · 2019
   Article
5. Possible Benefit and Validity of Supplements for Alcohol Use Disorder.Alcoholism, clinical and experimental research · 2019
   Review

Corrections and comments

• Comment on
  Effective Reduction in High Ethanol Drinking by Semisynthetic Tetracycline Derivatives.2016

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as